Literature DB >> 11547531

Bioterrorism: a threat for which we are ill prepared.

B Dhawan1, P Desikan-Trivedi, R Chaudhry, P Narang.   

Abstract

Of the weapons of mass destruction, the biological ones are the most feared and bioterrorism has become one of the most vicious threats to civilized society in recent times. Biological weapons have been sporadically used for centuries. Despite international regulations, there has been a global re-emergence of the threat of biological warfare. As many as 17 countries are suspected of either including or developing biological agents in their weapons programmes. In the past decade, a number of terrorist organizations with access to bioweapons technology have emerged. Current surveillance systems may be inadequate to detect biological attacks. The onset of illness is often delayed, thus the timing and location of such an event may be extremely difficult to identify. We are unfamiliar with most of the agents of biological warfare and are ill-equipped to handle the consequences of such an attack. In addition, there is no apparent coherent policy to handle a biological terrorist incident. Given the enormity of what is possible in the event of a biological attack, we must be prepared to detect, diagnose, epidemiologically characterize and respond appropriately to biological weapons. Of the potential biological weapons, smallpox and anthrax pose the greatest threats.

Entities:  

Mesh:

Year:  2001        PMID: 11547531

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  2 in total

1.  A global network for early warning and response to infectious diseases and bioterrorism: applied epidemiology and training programs, 2001.

Authors:  Hardeep S Sandhu; Christopher Thomas; Peter Nsubuga; Mark E White
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

2.  A mathematical simulation of the inflammatory response to anthrax infection.

Authors:  Rukmini Kumar; Carson C Chow; John D Bartels; Gilles Clermont; Yoram Vodovotz
Journal:  Shock       Date:  2008-01       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.